Forge Investment Outlook Q2 2024Road to Recovery: Private Market Accelerates in Q1
Forge Investment Outlook Q2 2024
Trading
Data
Solutions
Insights
About
Casma Therapeutics is a biopharma technology company that focuses on removal of damaged cell components to treat and prevent various diseases. Casma Therapeutics aims to reprogram autophagy methods, also known as the removal of infiltrates of cells that can damage and degrade them. The private company has brought together a team of clinical specialists and scientists all with a mission to treat patients where traditional drugs have failed.
Casma Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Casma Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Casma Therapeutics is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
